Bureau Veritas SA
PAR:BVI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
21.34
30.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Bureau Veritas SA
Bureau Veritas SA
Other Current Liabilities
Bureau Veritas SA
Other Current Liabilities Peer Comparison
TEP
AAA
ASY
SEC
ALNLF
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bureau Veritas SA
PAR:BVI
|
Other Current Liabilities
€879.2m
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
22%
|
|
|
Teleperformance SE
PAR:TEP
|
Other Current Liabilities
€760m
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
|
|
Alan Allman Associates SA
PAR:AAA
|
Other Current Liabilities
€20.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
132%
|
CAGR 10-Years
N/A
|
|
|
Assystem SA
PAR:ASY
|
Other Current Liabilities
€52.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-13%
|
|
|
Soditech SA
PAR:SEC
|
Other Current Liabilities
€1.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-5%
|
|
|
Neolife SA
PAR:ALNLF
|
Other Current Liabilities
€397.6k
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is Bureau Veritas SA's Other Current Liabilities?
Other Current Liabilities
879.2m
EUR
Based on the financial report for Jun 30, 2024, Bureau Veritas SA's Other Current Liabilities amounts to 879.2m EUR.
What is Bureau Veritas SA's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
22%
Over the last year, the Other Current Liabilities growth was 9%. The average annual Other Current Liabilities growth rates for Bureau Veritas SA have been 16% over the past three years , 26% over the past five years , and 22% over the past ten years .
You don't have any saved screeners yet
